US Patent 9308281 MRNA therapy for Fabry disease
Patent 9308281 was granted and assigned to Shire (pharmaceutical company) on April, 2016 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 9308281 MRNA therapy for Fabry disease
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
